Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients

Prostate

Volumn 45, Issue 1, 2000, Pages 72-79

  Mazzucchelli, Roberta ^a   Montironi, Rodolfo ^a   Santinelli, Alfredo ^a   Lucarini, Guendalina ^a   Pugnaloni, Armanda ^a   Biagini, Graziella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Angiogenesis; Prostate; Prostatic adenocarcinoma; Prostatic intraepithelial neoplasia; Vascular endothelial growth factor

Indexed keywords

BICALUTAMIDE; GOSERELIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; STROMA CELL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0033844219     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000915)45:1<72::AID-PROS9>3.0.CO;2-U     Document Type: Article

References (27)

1. CD 34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
2. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
3. Microvessel density in prostate cancer: Prognostic and therapeutic utility
4. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy
5. Comparison of microscopic vascularity in benign and malignant prostate tissue
6. Predictors of pathological stage in prostatic cancer: The role of neovascularity
7. Analysis of the capillary architecture in the precursor of prostate cancer: Recent findings and new concepts
8. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer. Preliminary results and therapeutic implication
9. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study
10. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
11. Commentary on prostatic neovascularization and vascular endothelial growth factor
12. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cell
13. Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cell
14. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
15. Architectural patterns in high-grade prostatic intraepithelial neoplasia
16. Vascular endothelial growth factor (VEGF) expression in prostatic tumors and its relationship to neuroendocrine cells
17. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation
18. Expression of π-class glutathione S-transferase: Two populations of high-grade prostatic intraepithelial neoplasia with different relationship to carcinoma
19. Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer?. A long-term retrospective study in Norway
20. Digital image analysis of proliferative index: Two distinct populations of high-grade prostatic intraepithelial neoplasia in close proximity to adenocarcinoma of the prostate
21. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
22. Association of vascular endothelial growth factor expression with intratumoral microvascular density and tumor cell proliferation in human epidermoid lung carcinoma
23. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
24. Precursors of prostatic cancer: Progression, regression and chemoprevention
25. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue
26. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression
27. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo